Thank you to our November guest bloggers, Dr. Robert Holt and the immunogenomics team, for sharing how their exciting work with DNA analysis is helping to make immunotherapy-based treatments most effective.
This month, we’re pleased to welcome Dr. Howard Lim, a medical oncologist at the BC Cancer Agency. Dr. Lim’s research focuses on uncovering new and improved solutions for those with colorectal cancer.
As well, the enrollment of one of Dr. Lim’s patients in the Personalized Onco-Genomics (POG) Program made news earlier this year, when a medication typically used to treat blood pressure was found to be effective for her colon cancer. While not every patient could expect the same result, the outcome is exciting and holds hope this discovery will lead to more.
Join me in reading along this month to learn more about Dr. Lim’s work.